Jeg har siden 1988 forsket primært på sarkomer, kreft i binde- og støttevev. I de senere år har vi fokusert på barnekreft.

Multiple talks, interviews and articles directed to the public, decision makers and politicians.

Established the CCBIO906 Course in Cancer Genomics

Vitenskapelig artikkel

• David S. Moura; Jesus Lopez-Marti; Hussein Tawbi et al. (2026). Validation of a Seven-Gene Predictive SIGNature for the Efficacy of Immuno-Oncology PD-1 Inhibitors in Patients with Sarcoma. (ekstern lenke)
• Toufik Naolou; Nadine Schadzek; Jan Mathis Hornbostel et al. (2025). Enhanced gelatin methacryloyl nanohydroxyapatite hydrogel for high-fidelity 3D printing of bone tissue engineering scaffolds. (ekstern lenke)
• Marie Elise Engkvist; Eva Wessel Stratford; Susanne Lorenz et al. (2017). Analysis of the miR-34 family functions in breast cancer reveals annotation error of miR-34b. (ekstern lenke)
• Heidi Lyng; Kirsti Landsverk; Elin Kristiansen et al. (2004). The response of malignant B lymphocytes to ionizing radiation: Geneexpression and genotype. (ekstern lenke)
• Tale Barøy; Chandra Sekhar Reddy Chilamakuri; Susanne Lorenz et al. (2016). Genome analysis of osteosarcoma progression samples identifies FGFR1 overexpression as a potential treatment target and CHM as a candidate tumor suppressor gene. (ekstern lenke)
• Anita Sveen; Bjarne Johannessen; Ina Andrassy Eilertsen et al. (2021). The expressed mutational landscape of microsatellite stable colorectal cancers. (ekstern lenke)
• Magne Nordang Skårn; Paul Noordhuis; Mengyu Wang et al. (2014). Generation and characterization of an immortalized human mesenchymal stromal cell line. (ekstern lenke)
• Kaja Christine Graue Berg; Peter Andreas Wold Eide; Ina Andrassy Eilertsen et al. (2017). Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies. (ekstern lenke)
• Even Holth Rustad; Eivind Coward; Emilie R Skytøen et al. (2017). Monitoring multiple myeloma by quantification of recurrent mutations in serum. (ekstern lenke)
• Laurence Bianchini; Loic Birtwisle; Esma Saada et al. (2013). Identification of PPAP2B as a novel recurrent translocation partner gene of HMGA2 in lipomas. (ekstern lenke)
• Kristine Kleivi; Guro E Lind; Chieu B Diep et al. (2007). Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses. (ekstern lenke)
• Vivi Ann Flørenes; Steinar Aamdal; Ola Myklebost et al. (1992). Levels of mm23 mRNA in metastatic malignant melanomas. Inverse correlation to disease progression. (ekstern lenke)
• Anne Forus; Vivi Ann Flørenes; Gunhild Mari Mælandsmo et al. (1994). The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas. (ekstern lenke)
• Gunhild Mari Mælandsmo; Jeanne-Marie Berner; Vivi Ann Flørenes et al. (1995). Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas - relationship to amplification and mRNA levels of CDK4 and CCND1. (ekstern lenke)
• Bjørn Skrede; Rune Blomhoff; Gunhild Mari Mælandsmo et al. (1992). Uptake of chylomicron remnant retinyl esters in human leukocytes in vivo. (ekstern lenke)
• Jillian Wise; Sigve Nakken; Chloe Beate Steen et al. (2020). Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series. (ekstern lenke)
• Ellen Tenstad; Anna Tourovskaia; Albert Folch et al. (2010). Extensive adipogenic and osteogenic differentiation of patterned human mesenchymal stem cells in a microfluidic device. (ekstern lenke)
• Hege Oma Ohnstad; Erik Braarød Paulsen; Paul Noordhuis et al. (2011). MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines. (ekstern lenke)
• G. Armengol; M. Tarkkanen; M. Virolainen et al. (1997). Recurrent gains of 1q, 8 and 12 in the Ewing family of tumors by cemparative genomic hybridisation. (ekstern lenke)
• Anna Wennerstrøm; Inger Marie Bowitz Lothe; Vandana Sandhu et al. (2014). Generation and Characterisation of Novel Pancreatic Adenocarcinoma Xenograft Models and Corresponding Primary Cell Lines. (ekstern lenke)
• Gustav Lehne; Unn-Hilde Grasmo-Wendler; Jeanne-Marie Berner et al. (2009). Upregulation of stem cell genes in multidrug resistant K562 leukemia cells. (ekstern lenke)
• A. Geurts van Kessel; N. R. Dos Santos; A. Simons et al. (1997). Cytogenetics and molecular genetics of bone and soft tissue tumours. (ekstern lenke)
• Sam Behjati; Patrick S. Tarpey; Kerstin Haase et al. (2017). Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma. (ekstern lenke)
• Mari Ann Kulseth; Peter Krajci; Ola Myklebost et al. (1995). Cloning and Characterization of Two Forms of Bovine Polymeric Immunoglobulin Receptor cDNA. (ekstern lenke)
• Junbai Wang; Trond Hellem Bø; Inge Jonasen et al. (2003). Tumor classification and marker gene prediction by feature selection and fuzzy c-means clustering using microarray data. (ekstern lenke)
• Anne Forus; B. Bjerkhagen; N. Sirvent et al. (2001). A well-differentiated liposarcoma with a new type of chromosome 12-derived markers. (ekstern lenke)
• Anita Sveen; Bjarne Johannessen; Solveig Margrete Knoph Klokkerud et al. (2024). Evolutionary mode and timing of dissemination of high-grade serous carcinomas. (ekstern lenke)
• Parmida Ranji; Emma Jonasson; Lisa Andersson et al. (2024). Deciphering the role of FUS::DDIT3 expression and tumor microenvironment in myxoid liposarcoma development. (ekstern lenke)
• Heidi Maria Namløs; Olga Zaikova; Bodil Bjerkehagen et al. (2017). Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report. (ekstern lenke)
• Gunhild Troen; Vigdis Nygaard; T. K. Jenssen et al. (2004). Constitutive expression of the AP-1 transcription factors c-jun, junD, junB and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma. (ekstern lenke)
• Heidi Lyng; Azadeh Badiee; Debbie H. Svendsrud et al. (2004). Profound influence of microarray scanner characteristics on gene expression ratios: analysis and procedure for correction. (ekstern lenke)
• Eivind Hovig; Ola Myklebost; Steinar Aamdal et al. (2001). Genterapi ved kreft. (ekstern lenke)
• Iwona Grad; Robert Hanes; Maria del Pilar Ayuda-Duran et al. (2021). Discovery of novel candidates for anti-liposarcoma therapies by medium-scale high-throughput drug screening. (ekstern lenke)
• Elin Hallan Naderi; Seham Skah; Hege Katrin Ugland et al. (2015). Bone marrow stroma-derived PGE<sub>2</sub> protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death. (ekstern lenke)
• Arne K. Sandvik; Ole Støren; Kristin Nørsett et al. (2001). Måling av genaktivitet med DNA mikromatriser (mikroarray). Molekylære og teknologiske prinsipper. (ekstern lenke)
• L Ottaviano; K-L Schaefer; M Gajewski et al. (2009). Molecular characterization of commonly used cell lines for bone tumor research. A trans-European EuroBoNet effort. (ekstern lenke)
• Anita Sveen; Bjarne Johannessen; Torstein Tengs et al. (2017). Multilevel genomics of colorectal cancers with microsatellite instability – clinical impact of JAK1 mutations and consensus molecular subtype 1. (ekstern lenke)
• Åslaug Helland; Odd Terje Brustugun; Sigve Nakken et al. (2017). High number of kinome-mutations in non-small cell lung cancer is associated with reduced immune response and poor relapse-free survival. (ekstern lenke)
• Anne Forus; Vivi Ann Flørenes; Gunhild Mari Mælandsmo et al. (1993). Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: Some amplica do not include MDM2. (ekstern lenke)
• Jakob K. Anninga; Anne-Marie Cleton-Jansen; Bass Hassan et al. (2014). Workshop Report on the 2nd Joint ENCCA/EuroSARC European Bone Sarcoma Network Meeting: Integration of Clinical Trials with Tumour Biology.. (ekstern lenke)
• Anne Forus; Jeanne-Marie Berner; Leonardo A. Meza-Zepeda et al. (1998). Molecular characterisation of a novel amplicon at 1q21-q22 in human sarcomas. (ekstern lenke)
• Ansastassia Serguienko; Peder Rustøen Braadland; Leonardo A. Meza-Zepeda et al. (2020). Accurate 3-gene-signature for early diagnosis of liposarcoma progression. (ekstern lenke)
• Heidi Maria Namløs; Magne Nordang Skårn; Deeqa Ahmed Mohamed Ali et al. (2022). miR-486-5p expression is regulated by DNA methylation in osteosarcoma. (ekstern lenke)
• Vivi Ann Flørenes; Ruth Holm; U. Lendahl et al. (1994). Expression of the neuroectodermal intermediate filament nestin in human melanomas. (ekstern lenke)
• Marieke L. Kuijjer; Elisabeth FP Peterse; BEWM van den Akker et al. (2013). IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma. (ekstern lenke)
• Anastassia Serguienko; Iwona Grad; Anna Wennerstrøm et al. (2015). Metabolic reprogramming of metastatic breast cancer and melanoma by Let-7a microRNA. (ekstern lenke)
• Marianne Brodtkorb Eide; Knut Liestøl; Ole Christian Lingjærde et al. (2010). Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones. (ekstern lenke)
• G. Maire; Anne Forus; C Foa et al. (2003). 11q13 alterations in two cases of hibernoma: large heterozygous deletions and rearrangement breakpoints near GARP in 11q13.5. (ekstern lenke)
• JMC Tubio; Y Li; YS Ju et al. (2014). Extensive transduction of non-reptitive DNA mediated by L1 retrotransposition in cancer genomes. (ekstern lenke)
• Jørn Henriksen; T.H. Aagesen; Gunhild Mari Mælandsmo et al. (2003). Amplification and overexpression of COPS3 in osteosarcomas potentially target TP53 for proteasome-mediated degradation. (ekstern lenke)
• Vigdis Nygaard; Anders Løland; Marit Holden et al. (2003). Effects of mRNA amplification on gene expression ratios in cDNA experiments estimated by analysis of variance. (ekstern lenke)
• Stine Henrichson Kresse; Magne Skårn; Hege Oma Ohnstad et al. (2008). DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH. (ekstern lenke)
• Junbai Wang; Ola Myklebost; Eivind Hovig (2003). MGraph: graphical models for microarray data analysis. (ekstern lenke)
• Tor-Kristian Jenssen; Mette Langaas; Winston P. Kuo et al. (2002). Analysis of repeatability in spotted cDNA microarrays. (ekstern lenke)
• Eric Roman; Leonardo A. Meza-Zepeda; Stine H. Kresse et al. (2008). Chromosomal aberrations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization. (ekstern lenke)
• Zepeda Leonardo Meza; Agate Noer; John Arne Dahl et al. (2008). High-resolution analysis of genetic stability of human adipose tissue stem cells cultured to senescence. (ekstern lenke)
• Stine Henrichson Kresse; HO Ohnstad; Erik Braarød Paulsen et al. (2009). LSAMP, a Novel Candidate Tumor Suppressor Gene in Human Osteosarcomas, Identified by Array Comparative Genomic Hybridization. (ekstern lenke)
• T.H Ågesen; Vivi Ann Flørenes; I. Molenaar et al. (2005). Expression patterns of cell cycle components in sporadic and neurofibromatosis type 1 related malignant peripheral nerve sheath tumors. (ekstern lenke)
• O Haug; Ola Myklebost; M Aldrin et al. (2004). Analysis of the humoral immune response to immunoselected phage-displayed peptides by a microarray-based method. (ekstern lenke)
• Mark J. P. Wolf; L. A. Aaltonen; Jadwiga Szymanska et al. (1997). Complexity of 12q13-22 amplicon in liposarcoma: Microsatellite repeat analysis. (ekstern lenke)
• Jeanne-Marie Berner; Patrick F.J. Kools; Anne Forus et al. (1997). HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas. (ekstern lenke)
• Geir Olav Hjortland; Leonardo Zepeda Meza; Klaus Beiske et al. (2011). Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma. (ekstern lenke)
• Marieke L. Kuijjer; Heidi Maria Namløs; Esther I. Hauben et al. (2011). mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts. (ekstern lenke)
• Stine Henrichson Kresse; Leonardo Zepeda Meza; Isidro Machado et al. (2012). Preclinical xenograft models of human sarcoma show nonrandom loss of aberrations. (ekstern lenke)
• E Roman; Leonardo Andres Zepeda Meza; Stine Henrichson Kresse et al. (2008). Chromosomal aberrations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization. (ekstern lenke)
• Mark J. P. Wolf; M. Tarkkanen; T. Hulsebos et al. (1999). Characterization of the 17p amplicon inhuman sarcomas - microsatellite marker analysis. (ekstern lenke)
• A. Simons; M. Schepens; J. Jeuken et al. (2000). Frequent allelic loss of 9p21 (p16INK4A) and other genomic imbalances in human malignant fibruos histiocytoma. (ekstern lenke)
• Florence Pedeutour; Anne Forus; J.M. Coindre et al. (1999). Structure of ring and giant rod marker chromosomes in adipose tissue tumors: A study combining fluorescent in situ hybridization, comparative genomic hybridization, molecular analyses and immunohistochemistry. (ekstern lenke)
• H Lyng; M Lando; RS Brovig et al. (2008). GeneCount: genome-wide calculation of absolute tumor DNA copy numbers from array comparative genomic hybridization data. (ekstern lenke)
• Anne Forus; Leonardo A. Meza-Zepeda; B. Bjerkhagen et al. (2001). Dedifferentiation of a WDLPS to a highly malignant osteogenic tumor is associated with high-level amplification og 12q14-q22 and gain of 1q22. (ekstern lenke)
• Arne K. Sandvik; O. Støren; K. Nørsett et al. (2000). DNA Mikroarray- molekylære og teknologiske prinsipper. (ekstern lenke)
• A. Simons; J. Jeuken; G. van de Zande et al. (2000). Frequent allelic loss of 9p21 (p16INK4A) and other genomic imbalances in human malignant fibruos histiocytoma. (ekstern lenke)
• Eivind Galteland; EA Sivertsen; D.H Svendsrud et al. (2005). Translocation t(14;18)and gain of chromosome 18/BCL2: effects on BCL2 exression and apoptosis in B-cell non-Hodgkin's lymphomas. (ekstern lenke)
• Anne Forus; M. L. Larramedny; Leonardo A. Meza-Zepeda et al. (2001). Dedifferentiation of a well-differentiated liposarcoma to a highly malignant metastatic osteosarcoma: amplification of 12q14 at all stages and gain of 1q22-q24 associated with metastases. (ekstern lenke)
• Stine Henrichson Kresse; Halfdan Rydbeck; Magne Skårn et al. (2012). Integrative Analysis Reveals Relationships of Genetic and Epigenetic Alterations in Osteosarcoma. (ekstern lenke)
• Vandana Sandhu; David C. Wedge; Inger Marie Bowitz Lothe et al. (2016). The genomic landscape of pancreatic and periampullary adenocarcinoma. (ekstern lenke)
• A. Simons; M. Schepens; Anne Forus et al. (1999). A novel chromosomal region of allelic loss, 4q32-q34, in human osteosarcomas revealed by representational difference analysis. (ekstern lenke)
• Heidi Maria Namløs; Stine Henrichson Kresse; Christoph Rainer Muller et al. (2012). Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern. (ekstern lenke)
• Leonardo A. Meza-Zepeda; Anne Forus; B. Lygren et al. (2002). Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21. (ekstern lenke)
• Eva Wessel Stratford; Jeanette L. Daffinrud; Else Munthe et al. (2014). The tankyrase-specific inhibitor JW74 affects cell cycle progression and induces apoptosis and differentiation in osteosarcoma cell lines. (ekstern lenke)
• Anne Forus; M. L. Larramedny; Leonardo A. Meza-Zepeda et al. (2001). Dedifferentiation of a well-differentiated liposarcoma to a highly malignant osteosarcoma:amplification of 12q14 at all stages and gain of 1q22-q24 associated with metastases. (ekstern lenke)
• Jacob Edward Wang; Jan Delabie; Hans-Christian Aasheim et al. (2002). Clustering of the SOM easily reveals distinct gene expression patterns: results of a reanalysis of lymphoma study. (ekstern lenke)
• Jeanne-Marie Berner; Anne Forus; A.E. Kahloun et al. (1996). Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas. (ekstern lenke)
• Constance H. Li; Stephenie D. Prokopec; Ren X. Sun et al. (2020). Sex differences in oncogenic mutational processes. (ekstern lenke)
• Anne-Mari Håkelien; Jan Christian Bryne; Kristine Gjul Harstad et al. (2014). The regulatory landscape of osteogenic differentiation. (ekstern lenke)
• S Safavi; S Järnum; C Vannas et al. (2015). HSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo. (ekstern lenke)
• Daniel Vodak; Susanne Lorenz; Sigve Nakken et al. (2018). Sample-Index Misassignment Impacts Tumour Exome Sequencing. (ekstern lenke)
• Robert Hanes; Iwona Grad; Susanne Lorenz et al. (2016). Preclinical evaluation of potential therapeutic targets in dedifferentiated liposarcoma. (ekstern lenke)
• Mandy L. Ballinger; Swetansu Pattnaik; Piyushkumar A. Mundra et al. (2023). Heritable defects in telomere and mitotic function selectively predispose to sarcomas. (ekstern lenke)
• Junbai Wang; Trond Hellem Bø; TH Bo et al. (2004). Tumor classification and marker gene prediction by feature selection and fuzzy c-means clustering using microarray data. (ekstern lenke)
• Kristine Misund; Davine Hofste op Bruinink; Eivind Coward et al. (2022). Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence. (ekstern lenke)
• Jeanne-Marie Berner; Christoph Rainer Muller; Marit Holden et al. (2006). Sampling effects on gene expression data from a human tumour xenograft. (ekstern lenke)
• Andreas Venizelos; Christina Engebrethsen; Wei Deng et al. (2022). Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy. (ekstern lenke)
• Ola Myklebost (2015). Norwegian Cancer Genomics Consortium: A platform for research on personalized cancer medicine in a public health system. (ekstern lenke)
• Even Holth Rustad; Hong Yan Dai; Håkon Hov et al. (2015). BRAF V600E mutation in early-stage multiple myeloma: good response to broad acting drugs and no relation to prognosis. (ekstern lenke)
• L. A. Meza-Zepeda; Stine Henrichson Kresse; AH Barragan-Polania et al. (2006). Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas.. (ekstern lenke)
• Tatiana Georgiesh; Heidi Maria Namløs; Nitin Sharma et al. (2021). Clinical and molecular implications of NAB2-STAT6 fusion variants in solitary fibrous tumour. (ekstern lenke)
• Gunhild Mari Mælandsmo; Eivind Hovig; Martina Skrede et al. (1996). Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts-1) ribozyme. (ekstern lenke)
• Junbai Wang; Jan Delabie; Hans-Christian aasheim et al. (2002). Clustering of the SOM easily reveals distinct gene expression patterns: results of a reanalysis of lymphoma study.. (ekstern lenke)
• Junbai Wang; LA Meza-Zepeda; Stine Henrichson Kresse et al. (2004). M-CGH: analysing microarray-based CGH experiments.. (ekstern lenke)
• Stine Henrichson Kresse; Heidi Maria Namløs; Susanne Lorenz et al. (2018). Evaluation of commercial DNA and RNA extraction methods for high-throughput sequencing of FFPE samples. (ekstern lenke)
• Junbai Wang; Ola Myklebost; Eivind Hovig et al. (2003). Tumor classification and marker gene prediction by feature selection and fuzzy c-means clustering using microarray data. (ekstern lenke)
• Eva Wessel Stratford; Monica Bostad; Castro Russell et al. (2013). Photochemical internalization of CD133-targeting immunotoxins efficiently depletes sarcoma cells with stem-like properties and reduces tumorigenicity. (ekstern lenke)
• Anne Forus; Therese Sørlie; Anne-Lise Børresen-Dale et al. (2001). Mikromatriser i kreftforskning: Nå trenger vi ikke å bare lete under gatelyktene!. (ekstern lenke)
• A. Lægreid; J. Komorowski; Arne K. Sandvik et al. (2001). DNA mikroarray- vindu mot tusentals gen. (ekstern lenke)
• N. Sirvent; Anne Forus; W. Lescaut et al. (2000). Characterization of centromere alterations in liposarcomas. (ekstern lenke)
• N. Sirvent; Anne Forus; W. Lescaut et al. (2000). Characterization of centromere alterations in liposarcomas. (ekstern lenke)
• Marieke L. Kuijjer; Halfdan Rydbeck; Stine Henrichson Kresse et al. (2012). Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data. (ekstern lenke)
• Irantzu Anzar Martinez de Lagran; Brandon Malone; Pubudu Saneth Samarakoon et al. (2023). The interplay between neoantigens and immune cells in sarcomas treated with checkpoint inhibition. (ekstern lenke)
• Kristin Andersen; Birgitte Smith-Sørensen; Kjetil Boye Pedersen et al. (2003). Interferon-gamma suppresses S100A4 transciption independently of apoptosis or cell cycle arrest. (ekstern lenke)
• Anne Forus; M. L. Larramedny; Leonardo A. Meza-Zepeda et al. (2000). Dedifferentiation of a WDLPS to a highly malignant osteogenic tumor is associated with high-level amplification of 12q14-q22 and gain of 1q22. (ekstern lenke)
• Marc Zapatka; Ivan Borozan; Daniel S. Brewer et al. (2020). The landscape of viral associations in human cancers. (ekstern lenke)
• Kadir C. Akdemir; Victoria T. Le; Sahaana Chandran et al. (2020). Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer. (ekstern lenke)
• Yuan Yuan; Young Seok Ju; Youngwook Kim et al. (2020). Comprehensive molecular characterization of mitochondrial genomes in human cancers. (ekstern lenke)
• Bernardo Rodriguez-Martin; Eva G. Alvarez; Adrian Baez-Ortega et al. (2020). Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition. (ekstern lenke)
• Jeanne-Marie Berner; Therese Sørlie; F. Mertens et al. (1999). Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors from patients with neurofibromatosis type 1. Studies of CDKN2A and other genes og the pRB pathway. (ekstern lenke)
• Matthew H. Bailey; William U. Meyerson; L. Jonathan Dursi et al. (2020). Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples. (ekstern lenke)
• Stine Henrichson Kresse; Jeanne-Marie Berner; Leonardi A Meza-Zepeda et al. (2005). Mapping and characterizatin of the amplicon near APOA2 in Iq23 in human sarcomas by FISH and array CGH. (ekstern lenke)
• Isidro Cortés-Ciriano; Jake June-Koo Lee; Ruibin Xi et al. (2020). Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing. (ekstern lenke)
• Cecilie Sandberg; Gabriel Altschuler; Jieun Jeong et al. (2013). Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome. (ekstern lenke)
• Chandra Sekhar Reddy Chilamakuri; Susanne Lorenz; Mohammed-Amin Madoui et al. (2014). Performance comparison of four exome capture systems for deep sequencing. (ekstern lenke)
• Deepika Kanojia; Yasunobu Nagata; Manoj Garg et al. (2015). Genomic landscape of liposarcoma. (ekstern lenke)
• Susanne Lorenz; Tale Barøy; Jinchang Sun et al. (2016). Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations. (ekstern lenke)

Konferanseforedrag

• Kristine Misund; Davine Hofste op Bruinink; Eivind Coward et al. (2017). Detection of mutations in Multiple Myeloma during different stages of disease. (ekstern lenke)
• Ola Myklebost (1999). Microarray-based analysis of gene expression. New tools for the diagnosis of problem cases? Invited plenary talk at the annual meeting of the Scandinavian sarcoma group. (ekstern lenke)
• Leonardo A. Meza-Zepeda; Anne Forus; A. B. Dahlberg et al. (2000). Positional cloning of novel genes form 1q21, a region frequently over-represented in human malignancies. (ekstern lenke)
• Ola Myklebost (1999). Microarray-based analysis of gene expression. New tools for the diagnosis of problem cases? Acta Othop. Scand. 70 suppl. 289: 24-25. (ekstern lenke)
• Anne Forus; A. Geurts van Kessel; Øystein Fodstad et al. (1996). Characterisation of lq21q22 amplifications in human sarcomas by CGH and molecular analysis. (ekstern lenke)
• Anne Forus; A. Geurts van Kessel; Øystein Fodstad et al. (1996). Characterisation of 1q21-q22 amplifications in human sarcomas by CGH and molecular analysis. (ekstern lenke)
• Ola Myklebost (2017). Sarcomas: Genomic Landscape and potential targets.. (ekstern lenke)
• Jeanne-Marie Berner; Leonardo A. Meza-Zepeda; Patrick F.J. Kools et al. (1997). The HMGIC gene is amplified, rearranged and overexpressed in a subset of human sarcomas. (ekstern lenke)
• Ola Myklebost (2012). Personalized cancer medicine. (ekstern lenke)
• Leonardo A. Meza-Zepeda; Anne Forus; Linda H. Godager et al. (1998). Characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas by Fluorescent in situ Hybridization (FISH). (ekstern lenke)
• Ragnhild A Lothe; Jeanne-Marie Berner; Therese Sørlie et al. (1998). Malignanat peripheral neve sheath tumours show frequent alterations of chromosome band 9p21. Studies of CDKN2A and other genes of the pRB pathway. (ekstern lenke)
• Ola Myklebost (1999). Global gene activity profiling by cDNA microarrays. (ekstern lenke)

Deltakelse i radio eller TV

• Ola Myklebost (1998). Richard Seed vil klone mennesker. (ekstern lenke)
• Ola Myklebost (1998). Richard Seed vil klone mennesker. (ekstern lenke)
• Ola Myklebost (1997). gentesting med DNA-chip-teknologi. (ekstern lenke)
• Ola Myklebost; Per Eystein Lønning; Anne Lise Ryel et al. (2016). Persontilpasset kreftmedisin – et spørsmål om prioritering. (ekstern lenke)
• Ola Myklebost; Per Eystein Lønning; Ole Alexander Opdalshei et al. (2016). På vei mot en klassedelt kreftomsorg?. (ekstern lenke)
• Ola Myklebost (2000). Problemer emd å finansisere postgenomisk forskning i Norge. (ekstern lenke)

Rettelse i tidsskrift

• Yuan Yuan; Young Seok Ju; Youngwook Kim et al. (2023). Publisher Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers (Nature Genetics, (2020), 52, 3, (342-352), 10.1038/s41588-019-0557-x). (ekstern lenke)
• Esther Rheinbay; Morten Muhlig Nielsen; Federico Abascal et al. (2023). Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes (Nature, (2020), 578, 7793, (102-111), 10.1038/s41586-020-1965-x). (ekstern lenke)
• Marc Zapatka; Ivan Borozan; Daniel S. Brewer et al. (2023). Author Correction: The landscape of viral associations in human cancers (Nature Genetics, (2020), 52, 3, (320-330), 10.1038/s41588-019-0558-9). (ekstern lenke)
• Claudia Calabrese; Natalie R. Davidson; Deniz Demircioğlu et al. (2023). Author Correction: Genomic basis for RNA alterations in cancer (Nature, (2020), 578, 7793, (129-136), 10.1038/s41586-020-1970-0). (ekstern lenke)
• Sergei Yakneen; Sebastian Martin Waszak; Brice Aminou et al. (2023). Author Correction: Butler enables rapid cloud-based analysis of thousands of human genomes (Nature Biotechnology, (2020), 38, 3, (288-292), 10.1038/s41587-019-0360-3). (ekstern lenke)
• Kadir C. Akdemir; Victoria T. Le; Sahaana Chandran et al. (2023). Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer (Nature Genetics, (2020), 52, 3, (294-305), 10.1038/s41588-019-0564-y). (ekstern lenke)
• Yuan Yuan; Young Seok Ju; Youngwook Kim et al. (2023). Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers (Nature Genetics, (2020), 52, 3, (342-352), 10.1038/s41588-019-0557-x). (ekstern lenke)
• Isidro Cortés-Ciriano; Jake June-Koo Lee; Ruibin Xi et al. (2023). Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing (Nature Genetics, (2020), 52, 3, (331-341), 10.1038/s41588-019-0576-7). (ekstern lenke)
• Shimin Shuai; Federico Abascal; Samirkumar B. Amin et al. (2022). Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower (Nature Communications, (2020), 11, 1, (734), 10.1038/s41467-019-13929-1). (ekstern lenke)
• Moritz Gerstung; Clemency Jolly; Ignaty Leshchiner et al. (2023). Author Correction: The evolutionary history of 2,658 cancers (Nature, (2020), 578, 7793, (122-128), 10.1038/s41586-019-1907-7). (ekstern lenke)
• Yilong Li; Nicola D. Roberts; Jeremiah A. Wala et al. (2023). Author Correction: Patterns of somatic structural variation in human cancer genomes (Nature, (2020), 578, 7793, (112-121), 10.1038/s41586-019-1913-9). (ekstern lenke)
• Ludmil B. Alexandrov; Jaegil Kim; Nicholas J. Haradhvala et al. (2023). Author Correction: The repertoire of mutational signatures in human cancer (Nature, (2020), 578, 7793, (94-101), 10.1038/s41586-020-1943-3). (ekstern lenke)
• Marek Cmero; Ke Yuan; Cheng Soon Ong et al. (2022). Author Correction: Inferring structural variant cancer cell fraction (Nature Communications, (2020), 11, 1, (730), 10.1038/s41467-020-14351-8). (ekstern lenke)
• Yiqun Zhang; Fengju Chen; Nuno A. Fonseca et al. (2022). Author Correction: High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations (Nature Communications, (2020), 11, 1, (736), 10.1038/s41467-019-13885-w). (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Leo Kager; Jeremy Whelan; U Dirksen et al. (2016). The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report. (ekstern lenke)
• José M.C. Tubio; Yilong Li; Young Seok Ju et al. (2014). Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. (ekstern lenke)
• Ola Myklebost (2015). Personalized cancer therapy for soft tissue sarcomas: progress and pitfalls. (ekstern lenke)

Populærvitenskapelig artikkel

• Ola Myklebost (2008). Det internasjonale kreftgenomprosjektet. (ekstern lenke)
• Ola Myklebost (1998). Richard Seed vil klone mennesker. (ekstern lenke)
• Ola Myklebost (1997). Vil forby kloning av mennesker. (ekstern lenke)
• Ola Myklebost (1997). Ingen etiske betenkeligheter. (ekstern lenke)
• Eivind Hovig; Ola Myklebost (2000). Menneskets DNA ferdig kartlagt. (ekstern lenke)

Konferanseabstrakt

• Rolf Inge Skotheim; Torfinn Nome; Gard O Sundby Thomassen et al. (2012). Identification of Fusion Transcripts in Colorectal Cancer by Combined RNA-seq and Exon Microarray Analyses. (ekstern lenke)
• Heidi Maria Namløs; Stine Henrichson Kresse; Ingrid Helene Garmann Østensen et al. (2010). Integrated analysis reveals overexpression of miRNA clusters in osteosarcomas. (ekstern lenke)
• Stine Henrichson Kresse; Halfdan Rydbeck; Ana Heslanyeth Barragan Polania et al. (2010). Integrative analysis of genome-wide genetic and epigenetic changes in human osteosarcomas. (ekstern lenke)
• Eric Roman; Leonardo A. Meza-Zepeda; Stine H. Kresse et al. (2005). Genome-Wide Screening of DNA Copy Number and Chromosomal Alterations in Oral Squamous Cell Carcinomas by Micro Array Comparative Genomic Hybridizations. (ekstern lenke)
• Baoyan Bai; Daniel Vodák; Sigve Nakken et al. (2019). Deep profiling of genetic aberrations and clonal evolution in follicular lymphoma. (ekstern lenke)
• T Baroy; Dahlia Hopmeier; Stine Henrichson Kresse et al. (2010). Characterisation of LSAMP, a novel candidate tumour suppressor gene in osteosarcomas. (ekstern lenke)

Medieintervju

• Eva Wessel Stratford; Ola Myklebost (2016). Vil behandle sjeldne kreftformer med personlig medisinering. (ekstern lenke)
• Ola Myklebost (2012). Norway invests in personalized cancer care. (ekstern lenke)
• Ola Myklebost (2014). Muligheter med livets strekkkode. (ekstern lenke)
• Ola Myklebost (2013). Storsatsing på bedre kreftbehandling. (ekstern lenke)
• Ola Myklebost (2014). "Dødstest" kan forusi risiko for å dø i løpet av fem år. (ekstern lenke)
• Ola Myklebost (2014). En ny generasjon kreftmedisin. (ekstern lenke)
• Ola Myklebost (2012). Når gener skrus av og på. (ekstern lenke)
• Ola Myklebost; Ragnhild A. Lothe (2012). Persontilpasset kreftbehandling. (ekstern lenke)
• Ola Myklebost (2012). Intervju om medisinske gjennombrudd. (ekstern lenke)
• Ola Myklebost (2013). Beregner seg frem til ny kreftbehandling. (ekstern lenke)
• Ola Myklebost (2012). Persontilpasset kreftmedisin. (ekstern lenke)
• Ola Myklebost (2013). Kreftforskning; Kan kampen vinnes?. (ekstern lenke)
• Ola Myklebost (2012). Om Norsk Kreftgenomikkonsortium. (ekstern lenke)
• Ola Myklebost (2013). Kartlegger kreftgenene. (ekstern lenke)
• Ola Myklebost (2012). På vei mot persontilpasset kreftmedisin. (ekstern lenke)
• Ola Myklebost (2012). Norway to bring cancer tests to the clinic. (ekstern lenke)
• Ola Myklebost (2012). Reading cancer's blueprint. (ekstern lenke)
• Ola Myklebost (2012). Skal kartleggja kreftgenar hos 4000 nordmenn. (ekstern lenke)
• Ola Myklebost (2012). Intervju om persontilpasset kreftmedisin. (ekstern lenke)
• Ola Myklebost (2015). “Helseforetakene driver beskyttede industribedrifter” Om svak satsing på fagutvikling og utprøvende behandling.. (ekstern lenke)
• Ola Myklebost (2015). Ny studie: Flaks eller uflaks bestemmer oftest om du får kreft – ikke usunn livsstil.Tilfeldige mutasjoner i DNA står bak to av tre krefttilfeller.. (ekstern lenke)

Fagbok

• Ola Myklebost (2000). Demper gen-håpet. Forskere advarer mot overdrevne forventninger til det som er kalt et stort gjennomslag for genforskning. (ekstern lenke)

Doktorgradsavhandling

• Gunhild Mari Mælandsmo; Øystein Fodstad; M.S. Grigorian et al. (1996). Reversal of the in vivo metastatic phenotype of human osteosarcoma cells by an anti-CAPL (Mts-1) ribozyme. (ekstern lenke)
• Vivi Ann Flørenes; Ruth Holm; U. Lendahl et al. (1994). Expression of the neuroectodermal intermediate filament nestin in human melanomas. (ekstern lenke)
• Vivi Ann Flørenes; Gunhild Mari Mælandsmo; Anne Forus et al. (1994). MDM2 gene amplification and transcript levels in human sarcomas - Relationship to p53 status. (ekstern lenke)
• Stine Henrichson Kresse; Ola Myklebost (2008). Chromosomal aberrations in human sarcomas identified using genomic microarrays. (ekstern lenke)

Vitenskapelig bokkapittel

• Ola Myklebost (1999). Undersøker tusenvis av gener. (ekstern lenke)

Fremhevet artikkel i media

• Steinar Aamdal; Heidi Beate Bentzen; Ole Johan Borge et al. (2017). Åpne Nordens grenser for forskning og behandling. (ekstern lenke)
• Ola Myklebost; Ragnhild A Lothe; Bjørn Tore Gjertsen et al. (2015). Bør hver kreftpasient bli et eget forskningsprosjekt?. (ekstern lenke)

Forelesning

• Ola Myklebost (2015). ”Cancer Who-done-it”. (ekstern lenke)

Leserbrev

• Isabelle Budin Ljøsne; Heidi Beate Bentzen; Jan Helge Solbakk et al. (2015). Genomsekvensering i forskning krever ny tilnærming til samtykke. (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.

Se publikasjonsliste på myklebost.uib.no

Main projects:

NoSarC, characterization of a national 3-year cohort of sarcoma patients and their samples, including establishment and characterization of disease models.

KidImmune, a study of autoimmunity in pediatric cancer patients.